Inventor · disambiguated record
Vuong Trieu
Also filed as: TRIEU VUONG · TRIEU VUONG N · TRIEU VUONG NGOC
39 granted patents·73 pending applications·1,063 citations·filing 1998–2025
98Inventor score
Top patents by PatentIndex Score
112 records- 0199US8911786B2Nanoparticle comprising rapamycin and albumin as anticancer agentDESAI NEIL P·Filed 2008·Granted Dec 16, 2014·76 cites·37 claims
- 0299US8314156B2Compositions and methods of delivery of pharmacological agentsDESAI NEIL P·Filed 2011·Granted Nov 20, 2012·137 cites·24 claims
- 0399US8138229B2Compositions and methods of delivery of pharmacological agentsDESAI NEIL P·Filed 2010·Granted Mar 20, 2012·160 cites·48 claims
- 0499US7923536B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2010·Granted Apr 12, 2011·160 cites·16 claims
- 0599US7820788B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2006·Granted Oct 26, 2010·211 cites·12 claims
- 0698US8846771B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2012·Granted Sep 30, 2014·48 cites·12 claims
- 0797US9295733B2SPARC binding ScFcsABRAXIS BIOSCIENCE LLC·Filed 2014·Granted Mar 29, 2016·35 cites·7 claims
- 0897US9012518B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Apr 21, 2015·36 cites·21 claims
- 0997US9012519B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Apr 21, 2015·38 cites·12 claims
- 1097US7332568B2Q3 SPARC deletion mutant and uses thereofABRAXIS BIOSCIENCE INC·Filed 2006·Granted Feb 19, 2008·56 cites·5 claims
- 1191US8415304B2Sparc and methods of use thereofTRIEU VUONG·Filed 2007·Granted Apr 9, 2013·15 cites·9 claims
- 1291US2025186359A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1390US8420603B2SPARC and methods of use thereofTRIEU VUONG·Filed 2006·Granted Apr 16, 2013·11 cites·8 claims
- 1485US9758786B2Compositions and methods for treating pancreatic cancerAUTOTELIC LLC·Filed 2016·Granted Sep 12, 2017·2 cites·7 claims
- 1585US2024065984A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2023·Application pending·0 cites
- 1682US6034053AEGF-isoflavone conjugates for the prevention of restenosisWAYNE HUGHES INST·Filed 1998·Granted Mar 7, 2000·58 cites·19 claims
- 1778US9763892B2Immediate release phospholipid-coated therapeutic agent nanoparticles and related methodsAUTOTELIC LLC·Filed 2016·Granted Sep 19, 2017·1 cites·30 claims
- 1876US7586008B2Propofol analogs, process for their preparation, and methods of useABRAXIS BIOSCIENCE INC·Filed 2008·Granted Sep 8, 2009·2 cites·28 claims
- 1976US2021322335A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2021·Application pending·0 cites
- 2075US2015050356A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2014·Application pending·0 cites
- 2174US2019022020A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2018·Application pending·0 cites
- 2273US2025382619A1Cancer therapy with tgf-beta-2 and irinotecan agentsGMP BIOTECHNOLOGY LTD·Filed 2025·Application pending·0 cites
- 2373US2019070201A1Fixed dose combination for pain relief without edemaMARINA BIOTECH INC·Filed 2018·Application pending·0 cites
- 2472US9678078B2Methods and compositions for personalized medicine by point-of-care devices for brain natriuretic peptideAUTOTELIC LLC·Filed 2014·Granted Jun 13, 2017·1 cites·1 claims
- 2572US8809507B2SPARC binding ScFvsTRIEU VUONG·Filed 2009·Granted Aug 19, 2014·0 cites·7 claims
- 2672US8445637B2SPARC binding peptides and uses thereofTRIEU VUONG·Filed 2009·Granted May 21, 2013·0 cites·34 claims
- 2772US2019091243A1Fixed dose combination for pain relief without edemaMARINA BIOTECH INC·Filed 2018·Application pending·0 cites
- 2872US2012128732A1Combinations and modes of administration of therapeutic agents and combination therapyTRIEU VUONG·Filed 2009·Application pending·0 cites
- 2971US8383358B2Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapyABRAXIS BIOSCIENCE LLC·Filed 2010·Granted Feb 26, 2013·2 cites·3 claims
- 3071US2024093198A1Tgf-beta therapeutics for age diseaseGMP BIOTECHNOLOGY LTD·Filed 2023·Application pending·0 cites
- 3171US2009263483A1Nanoparticle formulations and uses thereofDESAI NEIL P·Filed 2009·Application pending·0 cites
- 3269US9314537B2SPARC binding ScFcsABRAXIS BIOSCIENCE LLC·Filed 2014·Granted Apr 19, 2016·0 cites·7 claims
- 3369US9308279B2SPARC binding ScFvsABRAXIS BIOSCIENCE LLC·Filed 2014·Granted Apr 12, 2016·0 cites·7 claims
- 3469US2019275062A1Celocoxib Binding Antibodies and Uses ThereofMARINA BIOTECH INC·Filed 2019·Application pending·0 cites
- 3567US2017035787A1Fixed Dose Combination for Pain Relief Without EdemaAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 3667US2017071956A1Fixed Dose Combination for Pain Relief Without EdemaAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 3766US8821836B2SPARC binding peptides and uses thereofABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Sep 2, 2014·0 cites·11 claims
- 3866US2023201290A1Tgf-beta inhibition, agents and composition thereforGMP BIOTECHNOLOGY LTD·Filed 2022·Application pending·0 cites
- 3966US2019030049A1Celocoxib Binding Antibodies and Uses ThereofMARINA BIOTECH INC·Filed 2018·Application pending·0 cites
- 4066US2014302157A1Nanoparticle formulations and uses therofABRAXIS BIOSCIENCE LLC·Filed 2014·Application pending·0 cites
- 4166US2015190364A1Sparc and methods of use thereofABRAXIS BIOSCIENCE LLC·Filed 2014·Application pending·0 cites
- 4265US2024216359A1Treatment of neurological disordersGMP BIOTECHNOLOGY LTD·Filed 2024·Application pending·0 cites
- 4364US2016008371A1Fixed dose combination for pain relief without edemaAUTOTELIC LLC·Filed 2015·Application pending·0 cites
- 4464US2016022639A1Fixed dose combination for pain relief without edemaAUTOTELIC LLC·Filed 2015·Application pending·0 cites
- 4563US10053504B2SPARC binding ScFvsABRAXIS BIOSCIENCE LLC·Filed 2016·Granted Aug 21, 2018·0 cites·4 claims
- 4663US2018289620A1Nanoparticle formulations and uses thereofABRAXIS BIOSCIENCE LLC·Filed 2018·Application pending·0 cites
- 4763US2016243074A1Sparc and methods of use thereofABRAXIS BIOSCIENCE LLC·Filed 2016·Application pending·0 cites
- 4862US8916204B2SPARC and methods of use thereofABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Dec 23, 2014·0 cites·8 claims
- 4962US2012283205A1Compositions and methods of delivery of pharmacological agentsDESAI NEIL P·Filed 2012·Application pending·0 cites
- 5062US2019201508A1Methods for treating cancers using ace inhibitors, arb, or celecoxib and olmesartanMARINA BIOTECH INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 112 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Vuong Trieu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →